Original Research

Published on 02 Mar 2023

Identification of genes related to immune enhancement caused by heterologous ChAdOx1–BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods

in Vaccines and Molecular Therapeutics

Jing Li
FeiMing Huang
QingLan Ma
Wei Guo
KaiYan Feng
Tao Huang
Yu-Dong Cai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131051

4,043 views
7 citations

Original Research

Published on 01 Mar 2023

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study

in Vaccines and Molecular Therapeutics

Jeroen Geldof
Marie Truyens
João Sabino
Marc Ferrante
Jo Lambert
Hilde Lapeere
Tom Hillary
An Van Laethem
Kurt de Vlam
Patrick Verschueren

Frontiers in Immunology

doi 10.3389/fimmu.2023.1126351

2,935 views
5 citations

Brief Research Report

Published on 28 Feb 2023

Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice

in Vaccines and Molecular Therapeutics

Charu Aggarwal
Viswanathan Ramasamy
Amit Garg
Rahul Shukla
Navin Khanna

Frontiers in Immunology

doi 10.3389/fimmu.2023.1128784

3,761 views
2 citations

Brief Research Report

Published on 28 Feb 2023

Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose

in Vaccines and Molecular Therapeutics

Luca Perico
Marta Todeschini
Federica Casiraghi
Marilena Mister
Anna Pezzotta
Tobia Peracchi
Susanna Tomasoni
Piera Trionfini
Ariela Benigni
Giuseppe Remuzzi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1123158

2,727 views
6 citations

Original Research

Published on 28 Feb 2023

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

in Vaccines and Molecular Therapeutics

Joanna Waldock
Carol D. Weiss
Wei Wang
Min Z. Levine
Stacie N. Jefferson
Sammy Ho
Katja Hoschler
Brandon Z. Londt
Elisa Masat
Louise Carolan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129765

2,262 views
3 citations

Mini Review

Published on 28 Feb 2023

New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF

in Vaccines and Molecular Therapeutics

Zhi-Yan Liu
Min-Xue Sun
Man-Qi Hua
Han-Xu Zhang
Guang-Yan Mu
Shuang Zhou
Zhe Wang
Qian Xiang
Yi-Min Cui

Frontiers in Immunology

doi 10.3389/fimmu.2023.1098665

5,152 views
14 citations

Original Research

Published on 27 Feb 2023

Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy)

in Vaccines and Molecular Therapeutics

Pasquale Stefanizzi
Davide Ferorelli
Francesco Livio Scazzi
Antonio Di Lorenzo
Andrea Martinelli
Chiara Trinchera
Lorenza Moscara
Enrico Miniello
Danilo Di Bona
Silvio Tafuri

Frontiers in Immunology

doi 10.3389/fimmu.2023.1074246

1,854 views
5 citations

Review

Published on 24 Feb 2023

New-age vaccine adjuvants, their development, and future perspective

in Vaccines and Molecular Therapeutics

Shailendra Kumar Verma
Pooja Mahajan
Nikhlesh K. Singh
Ankit Gupta
Rupesh Aggarwal
Rino Rappuoli
Atul Kumar Johri

Frontiers in Immunology

doi 10.3389/fimmu.2023.1043109

39,581 views
61 citations

Original Research

Published on 23 Feb 2023

Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo

in Vaccines and Molecular Therapeutics

Nicholas J. Tursi
Ziyang Xu
Michaela Helble
Susanne Walker
Kevin Liaw
Neethu Chokkalingam
Toshitha Kannan
Yuanhan Wu
Edgar Tello-Ruiz
Daniel H. Park

Frontiers in Immunology

doi 10.3389/fimmu.2023.1072810

5,330 views
1 citation

Original Research

Published on 23 Feb 2023

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

in Vaccines and Molecular Therapeutics

George W. Carnell
Martina Billmeier
Sneha Vishwanath
Maria Suau Sans
Hannah Wein
Charlotte L. George
Patrick Neckermann
Joanne Marie M. Del Rosario
Alexander T. Sampson
Sebastian Einhauser

Frontiers in Immunology

doi 10.3389/fimmu.2023.1118523

3,726 views
9 citations

Original Research

Published on 23 Feb 2023

Development and validation of a rapid and easy-to-perform point-of-care lateral flow immunoassay (LFIA) for the detection of SARS-CoV-2 spike protein

in Vaccines and Molecular Therapeutics

Shamim Mohammad
Yuxia Wang
John Cordero
Christopher Watson
Robert Molestina
Sujatha Rashid
Rebecca Bradford

Frontiers in Immunology

doi 10.3389/fimmu.2023.1111644

4,377 views
6 citations

Review

Published on 22 Feb 2023

ADCC: An underappreciated correlate of cross-protection against influenza?

in Vaccines and Molecular Therapeutics

Rory D. de Vries
Katja Hoschler
Guus F. Rimmelzwaan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1130725

3,597 views
3 citations

Original Research

Published on 22 Feb 2023

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

in Vaccines and Molecular Therapeutics

Iván Sanz-Muñoz
Rosa López-Mongil
Javier Sánchez-Martínez
Laura Sánchez-de Prada
Marta Domínguez-Gil González
Diana Pérez-SanJose
Silvia Rojo-Rello
Cristina Hernán-García
Virginia Fernández-Espinilla
Raúl Ortiz de Lejarazu-Leonardo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1128302

1,923 views
1 citation

Original Research

Published on 21 Feb 2023

Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development

in Vaccines and Molecular Therapeutics

Yuchen Zhou
Jing Qu
Xiaomeng Sun
Zhuo Yue
Yingzi Liu
Keli Zhao
Fan Yang
Jie Feng
Xiaolei Pan
Yongxin Jin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129705

4,429 views
2 citations

Original Research

Published on 21 Feb 2023

Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants

in Vaccines and Molecular Therapeutics

Wenjuan Du
Rick Janssens
Anna Z. Mykytyn
Wentao Li
Dubravka Drabek
Rien van Haperen
Marianthi Chatziandreou
Melanie Rissmann
Joline van der Lee
Melissa van Dortmondt

Frontiers in Immunology

doi 10.3389/fimmu.2023.1111385

4,478 views
2 citations

Original Research

Published on 20 Feb 2023

A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component

in Vaccines and Molecular Therapeutics

Yuya Yoshioka
Kouji Kobiyama
Tomoya Hayashi
Motoyasu Onishi
Yosuke Yanagida
Takayuki Nakagawa
Masayuki Hashimoto
Anri Nishinaka
Jun Hirose
Yoshiji Asaoka

Frontiers in Immunology

doi 10.3389/fimmu.2023.1116238

6,446 views
6 citations

Navigation group

Articles

Identification of genes related to immune enhancement caused by heterologous ChAdOx1–BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study

Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice

Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF

Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy)

New-age vaccine adjuvants, their development, and future perspective

Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

Development and validation of a rapid and easy-to-perform point-of-care lateral flow immunoassay (LFIA) for the detection of SARS-CoV-2 spike protein

ADCC: An underappreciated correlate of cross-protection against influenza?

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development

Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants

A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component